NextPlat Corp. (NASDAQ:NXPL – Get Free Report) was the recipient of a large drop in short interest in the month of June. As of June 30th, there was short interest totaling 7,645 shares, a drop of 36.1% from the June 15th total of 11,956 shares. Based on an average trading volume of 40,854 shares, the short-interest ratio is presently 0.2 days. Approximately 0.5% of the company’s shares are sold short.
Analyst Upgrades and Downgrades
A number of research analysts have recently issued reports on NXPL shares. Weiss Ratings raised NextPlat from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, May 11th. Litchfield Hills Research started coverage on NextPlat in a report on Wednesday, June 24th. They issued a “buy” rating and a $11.00 target price for the company. Finally, Zacks Research raised NextPlat to a “hold” rating in a research note on Thursday, June 25th. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $11.00.
Check Out Our Latest Report on NXPL
NextPlat Price Performance
NextPlat (NASDAQ:NXPL – Get Free Report) last posted its quarterly earnings results on Thursday, May 14th. The company reported ($0.42) earnings per share for the quarter. The firm had revenue of $9.86 million for the quarter. NextPlat had a negative return on equity of 58.05% and a negative net margin of 23.14%. Equities research analysts expect that NextPlat will post -0.55 EPS for the current fiscal year.
Institutional Investors Weigh In On NextPlat
An institutional investor recently bought a new stake in NextPlat stock. Citadel Advisors LLC bought a new position in NextPlat Corp. (NASDAQ:NXPL – Free Report) during the third quarter, according to its most recent filing with the SEC. The firm bought 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned approximately 0.19% of NextPlat as of its most recent SEC filing. Institutional investors and hedge funds own 1.30% of the company’s stock.
NextPlat Company Profile
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.
Featured Stories
- Five stocks we like better than NextPlat
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.
